| Application number | Title of the application | Filing Date | Status |
|---|
| 08/149098 | COMPOSITIONS AND METHODS FOR TRANSDUCTION OF CELLS | Nov 7, 1993 | Abandoned |
| 08/146486 | TRANSCRIPTIONAL REGULATORY REGION DERIVED FROM THE K18 GENE | Oct 28, 1993 | Abandoned |
Array
(
[id] => 3589075
[patent_doc_number] => 05567604
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-22
[patent_title] => 'Anti-viral guanosine-rich oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/145704
[patent_app_country] => US
[patent_app_date] => 1993-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 10393
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/567/05567604.pdf
[firstpage_image] =>[orig_patent_app_number] => 145704
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/145704 | Anti-viral guanosine-rich oligonucleotides | Oct 27, 1993 | Issued |
Array
(
[id] => 3419828
[patent_doc_number] => 05434257
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-07-18
[patent_title] => 'Binding compentent oligomers containing unsaturated 3\',5\' and 2\',5\' linkages'
[patent_app_type] => 1
[patent_app_number] => 8/142785
[patent_app_country] => US
[patent_app_date] => 1993-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 48
[patent_no_of_words] => 27442
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/434/05434257.pdf
[firstpage_image] =>[orig_patent_app_number] => 142785
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/142785 | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages | Oct 25, 1993 | Issued |
Array
(
[id] => 3612570
[patent_doc_number] => 05510239
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-23
[patent_title] => 'Oligonucleotide modulation of multidrug resistance-associated protein'
[patent_app_type] => 1
[patent_app_number] => 8/136811
[patent_app_country] => US
[patent_app_date] => 1993-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4715
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/510/05510239.pdf
[firstpage_image] =>[orig_patent_app_number] => 136811
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/136811 | Oligonucleotide modulation of multidrug resistance-associated protein | Oct 17, 1993 | Issued |
| 08/141322 | TISSUE SPECIFIC TRANSGENE EXPRESSION | Oct 17, 1993 | Abandoned |
Array
(
[id] => 3690456
[patent_doc_number] => 05644045
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'X-linked adrenoleukodystrophy gene and corresponding protein'
[patent_app_type] => 1
[patent_app_number] => 8/136277
[patent_app_country] => US
[patent_app_date] => 1993-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 7197
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/644/05644045.pdf
[firstpage_image] =>[orig_patent_app_number] => 136277
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/136277 | X-linked adrenoleukodystrophy gene and corresponding protein | Oct 14, 1993 | Issued |
| 08/135488 | GENOMIC DNA OF HUMAN CHOLESTEROL 7ALPHA-HYDROXYLASE AND METHODS FOR USING IT | Oct 12, 1993 | Abandoned |
Array
(
[id] => 3591471
[patent_doc_number] => 05585479
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Antisense oligonucleotides directed against human ELAM-I RNA'
[patent_app_type] => 1
[patent_app_number] => 8/136741
[patent_app_country] => US
[patent_app_date] => 1993-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10413
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585479.pdf
[firstpage_image] =>[orig_patent_app_number] => 136741
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/136741 | Antisense oligonucleotides directed against human ELAM-I RNA | Oct 11, 1993 | Issued |
| 08/132259 | ANTI-SENSE OLIGODEOXYNUCLEOTIDE TO FIBROGENIC CYTOKINES AND USE THEREOF | Oct 5, 1993 | Abandoned |
| 08/131085 | GENE THERAPY OF THE NERVOUS SYSTEM | Sep 30, 1993 | Abandoned |
| 08/134132 | MUTANTS HAVING A DEFICIT OF FUNCTIONAL STEROID HORMONE RECEPTORS | Sep 30, 1993 | Abandoned |
| 08/127971 | MOUSE MODEL FOR HUNTINGTON'S DISEASE AND RELATED DNA SEQUENCES | Sep 26, 1993 | Abandoned |
| 08/123188 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES | Sep 19, 1993 | Abandoned |
Array
(
[id] => 3631671
[patent_doc_number] => 05610011
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => 'Virulence-encoding DNA sequences of Strepococcus suis and related products and methods'
[patent_app_type] => 1
[patent_app_number] => 8/119125
[patent_app_country] => US
[patent_app_date] => 1993-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 21521
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/610/05610011.pdf
[firstpage_image] =>[orig_patent_app_number] => 119125
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/119125 | Virulence-encoding DNA sequences of Strepococcus suis and related products and methods | Sep 19, 1993 | Issued |
Array
(
[id] => 3611054
[patent_doc_number] => 05589611
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'Disease resistance gene from maize and its use for disease resistance as a selectable marker and as a gene identification probe'
[patent_app_type] => 1
[patent_app_number] => 8/123761
[patent_app_country] => US
[patent_app_date] => 1993-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5406
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589611.pdf
[firstpage_image] =>[orig_patent_app_number] => 123761
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/123761 | Disease resistance gene from maize and its use for disease resistance as a selectable marker and as a gene identification probe | Sep 16, 1993 | Issued |
Array
(
[id] => 3585667
[patent_doc_number] => 05552311
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Purine nucleoside phosphorylase gene therapy for human malignancy'
[patent_app_type] => 1
[patent_app_number] => 8/122321
[patent_app_country] => US
[patent_app_date] => 1993-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8347
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552311.pdf
[firstpage_image] =>[orig_patent_app_number] => 122321
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/122321 | Purine nucleoside phosphorylase gene therapy for human malignancy | Sep 13, 1993 | Issued |
| 08/121435 | MURINE IL-2RY CDNA AND USES THEREOF | Sep 13, 1993 | Abandoned |
Array
(
[id] => 3468733
[patent_doc_number] => 05427592
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-27
[patent_title] => 'Intact seed-based delayed-released nutrient supplement for mushroom cultivation'
[patent_app_type] => 1
[patent_app_number] => 8/120890
[patent_app_country] => US
[patent_app_date] => 1993-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9037
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/427/05427592.pdf
[firstpage_image] =>[orig_patent_app_number] => 120890
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/120890 | Intact seed-based delayed-released nutrient supplement for mushroom cultivation | Sep 12, 1993 | Issued |
| 08/116669 | TREATMENT OF HUMAN TUMORS BY GENETIC TRANSFORMATION OF HUMAN TUMOR CELLS | Sep 2, 1993 | Abandoned |
